To investigate the immune-modulating effect in the tumor microenvironment after BJIKT and/or anti-PD-L1 treatment, we analyzed the proportion of tumor-associated lymphocytes, such as T-cells and NK cells in tumor tissues. This evidence concerns the gene CD274 and neoplasm.